FluoroSpot Plus: Human IL-22/IFN-γ/IL-5/IL-17A FSP-18010803-2 from Mabtech AB

Product Specs
ItemFluoroSpot Plus: Human IL-22/IFN-γ/IL-5/IL-17A
CompanyMabtech AB
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberFSP-18010803-2
Quantity2 plate
ApplicationsFluoroSpot
Reactivityhuman
Detection TargetIL-22,IFN-γ,IL-5,IL-17A
NCBI Full Gene Nameinterleukin 22, interferon gamma, interleukin 17A, interleukin 5
NCBI Gene AliasesIL17, IL-17, IL-17A, EDF, zcyto18, IL-TIF, IL-22, IL-21, IL-D110, TIFa, ILTIF, IMD69, CTLA8, IFG, IL-5, TIFIL-23, TRF, IFI, CTLA-8, ILA17
Formatpre-coated plates
ComponentsDIG-conjugated detection mAb (MT7B27),BAM-conjugated detection mAb (7-B6-1),Biotinylated detection mAb (5A10),WASP-conjugated detection mAb (MT504),Anti-DIG-380,Anti-BAM-490,SA-550,Anti-WASP-640,Anti-CD3 mAb,Anti-CD28 mAb (CD28-A),FluoroSpot enhancer,Pre-coated FluoroSpot plates (mAbs MT12A3, 1-D1K, TRFK5, and MT44.6)

Box 1233

Nacka Strand, SE-131 28

Sweden

Phone: +46 8 716 27 00
+46 8 716 27 01

(1) Impact of SARS-CoV-2 variants on the total CD4⁺ and CD8⁺ T cell reactivity in infected or vaccinated individualsCell reports. MedicineJuly 20, 2021Tarke A, Sidney J, Methot N, Yu ED, Zhang Y, Dan JM, Goodwin B, Rubiro P, Sutherland A, Wang E, et al.

(2) Unique Cholangiocyte-Targeted IgM Autoantibodies Correlate With Poor Outcome in Biliary AtresiaHepatology (Baltimore, Md.)May 1, 2021Luo Y, Brigham D, Bednarek J, Torres R, Wang D, Ahmad S, Mack CL.

(3) Prognostic significance of interleukin-17A-producing colorectal tumour antigen-specific T cellsBritish journal of cancerApril 1, 2021Thomson A, Bento DFC, Scurr MJ, Smart K, Somerville MS, Keita ÅV, Gallimore A, Godkin A.

(4) Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinomaCancer immunology, immunotherapy : CIIApril 1, 2021Leuchte K, Staib E, Thelen M, Gödel P, Lechner A, Zentis P, Garcia-Marquez M, Waldschmidt D, Datta RR, Wahba R, et al.

(6) Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge studyThe Lancet. Infectious diseasesApril 1, 2020Liebowitz D, Gottlieb K, Kolhatkar NS, Garg SJ, Asher JM, Nazareno J, Kim K, McIlwain DR, Tucker SN.

(7) Myelin oligodendrocyte glycoprotein revisited-sensitive detection of MOG-specific T-cells in multiple sclerosisJournal of autoimmunityAugust 1, 2019Bronge M, Ruhrmann S, Carvalho-Queiroz C, Nilsson OB, Kaiser A, Holmgren E, Macrini C, Winklmeier S, Meinl E, Brundin L, et al.

(8) Variability in German Cockroach Extract Composition Greatly Impacts T Cell Potency in Cockroach-Allergic DonorsFrontiers in immunologyJanuary 1, 2019Birrueta G, Frazier A, Pomés A, Glesner J, Filep S, Schal C, Jeong KY, McMurtrey C, Vander Schans T, Hildebrand WH, et al.

(10) Microbiota epitope similarity either dampens or enhances the immunogenicity of disease-associated antigenic epitopesPloS oneJanuary 1, 2018Carrasco Pro S, Lindestam Arlehamn CS, Dhanda SK, Carpenter C, Lindvall M, Faruqi AA, Santee CA, Renz H, Sidney J, Peters B, et al.

(12) Antigen delivery to dendritic cells shapes human CD4+ and CD8+ T cell memory responses to Staphylococcus aureusPLoS pathogensMay 1, 2017Uebele J, Stein C, Nguyen MT, Schneider A, Kleinert F, Tichá O, Bierbaum G, Götz F, Bekeredjian-Ding I.

(13) Expanded lung T-bet+RORγT+ CD4+ T-cells in sarcoidosis patients with a favourable disease phenotypeThe European respiratory journalAugust 1, 2016Kaiser Y, Lepzien R, Kullberg S, Eklund A, Smed-Sörensen A, Grunewald J.

(14) Validation of an IFNγ/IL2 FluoroSpot assay for clinical trial monitoringJournal of translational medicineJune 14, 2016Körber N, Behrends U, Hapfelmeier A, Protzer U, Bauer T.

(16) Human infant respiratory syncytial virus (RSV)-specific type 1 and 2 cytokine responses ex vivo during primary RSV infectionThe Journal of infectious diseasesJune 15, 2007Lee FE, Walsh EE, Falsey AR, Lumb ME, Okam NV, Liu N, Divekar AA, Hall CB, Mosmann TR.

FluoroSpot Plus: Human IL-22/IFN-gamma/IL-5/IL-17A